An endocrine programme enquiry in Cuba becomes clearer when the records identify the gland, the diagnosis, and the current specialist question. CubaHeal’s programme includes several different conditions, so preparation should be…
AllAutoimmune & Neurological ConditionsCardiovascularChild DevelopmentCuba Travel & VisaCuba’s AchievementsCubaHeal NewsDermatologyEducationEndocrinologyGeriatricGynecologyInternational CollaborationMedical (General)NeurologyOncologyOphthalmologyOrthopedicPsychiatrySubstance Abuse RehabilitationTravel InsuranceUncategorized
Patients exploring endocrine tumour and cancer care in Cuba need to identify the affected gland and the confirmed diagnosis. CubaHeal’s programme discusses several gland-related pathways, including pituitary and thyroid conditions. Not…
Diabetes insipidus occurs as a result of vasopressin deficiency (antidiuretic hormone caused by a hypothalamic-pituitary disorder, which is known as central diabetes insipidus) or by resistance of the kidneys to vasopressin (nephrogenic diabetes insipidus). The disease is primarily characterized by polyuria (abundant urine excretion) and polydipsia (pathological need to drink water) and is confirmed by...
Introduction Diabetic foot ulcers (DFUs) are a severe complication of diabetes mellitus, leading to significant morbidity and an increased risk of lower limb amputations. The management of DFUs presents a substantial challenge in healthcare, necessitating innovative treatments to enhance healing and reduce amputation rates. One such advancement is Heberprot-P, a novel therapeutic approach developed to...
For Diabetic Foot Ulcer, Heberprot-P is a drug developed by the Center for Genetic Engineering and Biotechnology (CIGB) in 2007 in Cuba. Diabetes is no longer considered life threatening, nonetheless diabetes and complications due to diabetes, when not under control, remain to be sixth leading cause of death having a higher mortality rate than some...